Article

Rheumatoid Arthritis Quiz: Cardiovascular Events and RA Treatments

Author(s):

Ingrid Torjesen

It is well-known that rheumatoid arthritis patients have a heightened risk of cardiovascular events, but how do RA treatments affect this risk? Test your knowledge with this quiz.

Is the following statement true or false?

Studies have shown that immunomodulators reduce cardiovascular events among the general population but that these drugs have no impact on risk of cardiovascular events in rheumatoid arthritis patients.


Related Videos
Abdul Abdellatif, MD: More Gout Education Needed for Nephrologists
Violeta Popov, MD, PhD | Credit: ACG
Satish Rao, MD, PhD | Credit: ACG
Jonathan Barratt, MD, PhD | Credit: IgA Nephropathy Foundation
Jonathan Barratt, MD, PhD | Credit: IgA Nephropathy Foundation
Jonathan Barratt, MD, PhD | Credit: IgA Nephropathy Foundation
Jonathan Barratt, MD, PhD | Credit: IgA Nephropathy Foundation
Jonathan Barratt, MD, PhD | Credit: IgA Nephropathy Foundation
Ladan Zand, MD: Evaluating Obinutuzumab in Primary FSGS and Further Research
ADORING Trial Open-Label Extension: Tapinarof Cream 1% Results in Atopic Dermatitis
Related Content
10-Year Follow-Up Shows Lasting Benefits of Bariatric Surgery for Teens with Severe Obesity
October 30th 2024

10-Year Follow-Up Shows Lasting Benefits of Bariatric Surgery for Teens with Severe Obesity

Chelsie Derman
Kidney Compass default thumbnail with podcast logo and headshots of hosts Brendon Neuen and Shikha Wadhwani.
October 28th 2024

Kidney Compass: FLOW Insights from Kidney Week 2024, with Katherine Tuttle, MD

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
Jonathan Barratt, MBChB, PhD, Mayer Professor of Renal Medicine, University of Leicester, Leicester, United Kingdom
October 30th 2024

Felzartamab Slows IgAN Decline in New Phase 2 Data

Victoria Johnson
Kidney Compass default thumbnail with podcast logo and headshots of hosts Brendon Neuen and Shikha Wadhwani.
October 27th 2024

Kidney Compass: Semaglutide for Nondiabetic Kidney Disease, with Hiddo Heerspink, PhD, PharmD, at Kidney Week 2024

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
Credit: US Food and Drug Administration
October 29th 2024

Abeona Completes Resubmission of Pz-cel Cell-Based Gene Therapy BLA for RDEB

Victoria Johnson
Low-Dose CAR-T Shows Efficacy in Pediatric Systemic Lupus Erythematosus
October 29th 2024

Low-Dose CAR-T Shows Efficacy in Pediatric Systemic Lupus Erythematosus

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.